J Korean Soc Menopause. 2013 Aug;19(2):87-92. Korean.
Published online Aug 27, 2013.
Copyright © 2013 by The Korean Society of Menopause
Original Article

A Clinical Analysis of Patients with Premature Ovarian Failure: Compliance with Hormonal Treatment

Hee Suk Lee, M.D.,1 Ji Hoon Ok, M.D.,1 Joo Myung Kim, M.D., Ph.D.,2 and Yeon Jean Cho, M.D., Ph.D.1
    • 1Department of Obstetrics and Gynecology, Dong-A University Medical Center, Dong-A University, College of Medicine, Busan, Korea.
    • 2Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea.
Received June 09, 2013; Revised July 10, 2013; Accepted July 23, 2013.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).

Abstract

Objectives

To analyze the clinical features of premature ovarian failure (POF) and patients' compliance with hormonal treatment.

Methods

A retrospective analysis of 126 patients diagnosed with POF was selected between January 2004 and December 2007. The clinical, etiologic features and treatment compliance were evaluated.

Results

The mean age of diagnosis was 33.2 ± 5.2 years. The mean value of follicle stimulating hormone was 78.8 ± 28.8 IU/L. The most common symptom was amenorrhea or oligomenorrhea (54%). Eighty-eight patients were married and 22 of them visited our clinic due to infertility. The most common etiology was unknown (54.8%) and the second most common cause was iatrogenic (29.4%). Only 61 patients underwent hormonal treatment (48.4%). The remaining 11 patients did not undergo hormonal treatment due to other medical conditions such as breast cancer or liver disease; however, they were followed-up regularly (8.7%). Among the treatment group, only 37 patients were followed-up over a period of 12 months (60.7%).

Conclusion

About half of the women diagnosed with POF did not accept their own problems and therefore delayed essential treatment. Clinicians should educate the importance of early treatment for preventing degenerative changes.

Keywords
Compliance; Hormone replacement therpay; Premature ovarian failure; Primary ovarian insufficiency

Tables

Table 1
Patients' characteristics (n = 126)

Table 2
Etiology of premature ovarian failure

Table 3
Patients' compliance with hormonal treatment

Table 4
Age group and hormonal treatment

Table 5
Etiology and hormonal treatment

Notes

This work is supported by the Dong-A University research fund.

References

    1. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604–606.
    1. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003;18:199–206.
    1. Panay N, Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynaecol 2009;23:129–140.
    1. North American Menopause Society. Menopause Practice: a clinician's guide. 3rd ed. Cleveland, OH: North American Menopause Society; 2007.
    1. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360:606–614.
    1. van Kasteren YN, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999;5:483–492.
    1. Kalu E, Panay N. Spontaneous premature ovarian failure: management challenges. Gynecol Endocrinol 2008;24:273–279.
    1. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65:161–166.
    1. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006;13:265–279.
    1. Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol 1999;52:303–307.
    1. de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 2002;155:339–345.
    1. van der Stege JG, Groen H, van Zadelhoff SJ, Lambalk CB, Braat DD, van Kasteren YM, et al. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause 2008;15:23–31.
    1. Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause 2007;14:567–571.
    1. Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol 2005;162:1089–1097.
    1. Jacobsen BK, Heuch I, Kvale G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003;157:923–929.
    1. Kim TH, Lee HH, Chung SH, Yang YJ. Non-vertebral fractures due to recurrent falls after premature menopause. J Korean Soc Menopause 2010;16:52–54.
    1. Lee JY, Chung HW. Premature ovarian failure. J Korean Soc Menopause 2009;15:79–86.
    1. Huh JS, Seo SK, Kim MR, Chung HW, Yoon BK, Lee BS, et al. Retrospective multicenter study on clinical aspects in premature ovarian failure. J Korean Soc Menopause 2011;17:160–165.

Metrics
Share
Tables

1 / 5

PERMALINK